Isolation of Mycobacterium branderi, an unusual species from an acute myelogenous leukemia patient
We report a case of pulmonary infection caused by Mycobacterium branderi, a slow growing non-tuberculosis mycobacteria, in a patient with acute myelogenous leukemia. The pulmonary disease was treated successfully with the combination of Ciprofloxacin, Doxycycline and Clarithromycin. M. branderi may...
Guardado en:
Autores principales: | Majid Marjani, Maham Farshidpour, Payam Tabarsi, Fatemeh-Maryam Sheikholslami, Parissa Farnia |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c75b7285d03c4b56a7280ff3dda83bfc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Update on the management of Philadelphia chromosome positive chronic myelogenous leukemia: role of nilotinib
por: Emole J, et al.
Publicado: (2016) -
Novel Treatment Strategies Utilizing Immune Reactions against Chronic Myelogenous Leukemia Stem Cells
por: Maiko Matsushita
Publicado: (2021) -
JKST6, a novel multikinase modulator of the BCR-ABL1/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous leukemia
por: Haidée Aranda-Tavío, et al.
Publicado: (2021) -
Atypical Chronic Myelogenous Leukemia, BCR-ABL1 Negative: Diagnostic Criteria and Treatment Approaches
por: Panagiotis T. Diamantopoulos, et al.
Publicado: (2021) -
Assessment of Oral Chemotherapy Nonadherence in Chronic Myeloid Leukemia Patients Using Brief Measures in Community Cancer Clinics: A Pilot Study
por: Terry C. Davis, et al.
Publicado: (2021)